Plasma/serum MMP-9 concentrations are significantly higher in untreated early-CLL patients (stage A) than in healthy controls [78,81,127] but fall to near-control levels in patients in remission [81,92] (Table 1). Here, MMP9 is linked to B-cell chronic lymphocytic leukemia.